559 Biomarker correlates of clinical response with FLT3L/nivo backbone treatment in the multi-cohort phase 1 PORTER platform trial in metastatic castration-resistant prostate cancer patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.